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Abstract
The low pH of the stomach serves as a barrier to ingested microbes and must be overcome or bypassed when delivering
live bacteria for vaccine or probiotic applications. Typically, the impact of stomach acidity on bacterial survival is evaluated
in vitro, as there are no small animal models to evaluate these effects in vivo. To better understand the effect of this low pH
barrier to live attenuated Salmonella vaccines, which are often very sensitive to low pH, we investigated the value of the
histamine mouse model for this application. A low pH gastric compartment was transiently induced in mice by the injection
of histamine. This resulted in a gastric compartment of approximately pH 1.5 that was capable of distinguishing between
acid-sensitive and acid-resistant microbes. Survival of enteric microbes during gastric transit in this model directly correlated
with their in vitro acid resistance. Because many Salmonella enterica serotype Typhi vaccine strains are sensitive to acid, we
have been investigating systems to enhance the acid resistance of these bacteria. Using the histamine mouse model, we
demonstrate that the in vivo survival of S. Typhi vaccine strains increased approximately 10-fold when they carried a sugar-
inducible arginine decarboxylase system. We conclude that this model will be a useful for evaluating live bacterial
preparations prior to clinical trials.
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Introduction
Live recombinant attenuated Salmonella vaccines (RASVs) for
humans are typically derived from Salmonella enterica serovar Typhi.
However, S. Typhi is host restricted to humans, thus preclinical
vaccine research and development relies on the closely related
Salmonella enterica serovar Typhimurium as a model, since S.
Typhimurium causes a disease in mice very similar to human
typhoid [1]. Use of the S. Typhimurium mouse model has led to a
large number of important insights into Salmonella pathogenesis
and methods to attenuate these bacteria. However, there are a
number of important differences between the two serovars and the
ways they interact with their respective hosts that, if not
understood and addressed, can result in failure at the clinic.
One such area that has been relatively overlooked is the impact of
the gastric environment on vaccine viability and subsequent
interactions with the host.
The gastric acid produced by the stomach serves an important
barrier function in preventing host infection by enteric pathogens
[2–4]. The pH of the gastric environment varies depending on the
host species, but is routinely very low [5]. The low pH rapidly
inactivates or kills the vast majority of ingested microbes [6]. To
cope with the challenge that a low pH gastric environment poses,
enteric microbes have evolved a variety of acid resistance
strategies. These include such systems as the highly potent urease
of Helicobacter pylori, amino acid decarboxylases such as glutamate,
arginine and lysine decarboxylases and the acid tolerance response
found in c-proteobacteria [7–12]. Induction of these systems,
usually by exposure to moderately acidic conditions, renders the
infecting microbe temporarily resistant to low pH [12–14]. The
level of protection from low pH provided by these systems depends
on the properties of the individual enzymes and the microenvi-
ronment of the low pH compartment, but generally, these are
highly successful strategies for transiting through the gastric
environment.
Problems arise when desirable microbes, such as RASVs, need
to be introduced into humans via the oral route. There is a
fundamental difference between S. Typhi and S. Typhimurium in
that S. Typhi is more acid-sensitive than S. Typhimurium [15].
There is also a fundamental difference in the gastric biology of
mice and humans. Prior to immunization, mice and humans fast
(usually 4–6 hours) to empty the upper portion of the gastroin-
testinal tract and reduce variations in vaccine invasion into M cells
of the gut associated lymphoid tissue (GALT) due to the presence
of food. In mice, fasting has the added benefit of increasing gastric
pH. The normal murine gastric pH is around 3.0, and rises to 4.0
following a fast [16]. In humans, however, the normal stomach pH
drops below 2.0 during fasting conditions [17,18]. In the context of
an oral immunization, the fasted mouse stomach poses a mild
challenge, while the fasted human stomach is hostile enough to
eradicate most (if not all) of the incoming vaccine cells.’’ To further
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complicate matters, RASVs are not usually cultured under
conditions that induce acid resistance, thus the cells enter the
host unprepared for the challenge the gastric environment presents
[19]. RASVs may also contain mutations that render them more
sensitive to acidic pH than wild-type strains [15,20]. These
problems make it difficult to reliably predict the survival of RASVs
following inoculation and may hamper our understanding of
Salmonella pathogenesis and RASV immunogenicity. Thus, a
mouse model that more closely mimics the low gastric pH of
humans may provide additional insights to guide the development
and formulation of RASVs for human use.
The problem gastric transit poses for RASVs has by no means
been overlooked. Vaccines are usually administered in conjunction
with a means to protect the cells from gastric acid, such as an
antacid [21–24] or in a gel-coated capsule [25,26]. These
formulations are effective, but they prevent the target microbe
from experiencing the low pH environment of the stomach and
thus the cells do not receive important positional signals that aid
them in preparing to colonize the intestine and invade host tissues
[27–31]. To address this issue, we have developed a regulated
acid-resistance strategy using arginine decarboxylase that dramat-
ically increases the survival of acid-sensitive Salmonella Typhi
vaccines strains at pH 3.0 and 2.5 in vitro [32]. However, for this
system to be effective in a vaccine context, it must increase survival
not only in vitro, but also during in vivo gastric transit.
In mice, the subcutaneous administration of histamine results in
a rapid and significant increase in hydrochloric acid secretion by
the parietal cells of the stomach via signaling through the H2
receptors [33–36]. Although originally designed to mimic acid
reflux in humans, this model may also be suitable for microbial
infection and immunization scenarios, as it was previously used to
establish the importance of low gastric pH as a barrier to infection
[4]. Thus, the purpose of this study was two-fold. The first goal
was to determine the suitability of the histamine mouse model as a
means to mimic the low pH environment of the human stomach
and gain insight into the impact of the in vivo gastric environment
on the survival of RASVs and other enteric microbes. The second
goal was to use the histamine mouse model to evaluate the in vivo
survival of attenuated S. Typhi strains containing a rhamnose-
regulated arginine decarboxylase acid resistance system. This
system significantly improves survival during in vitro low pH
challenge [32]. Thus, we hypothesized that the presence of this
system would also increase the ability of acid-sensitive strains of S.
Typhi to reach the intestinal tract in vivo. We found that survival
of a variety of wild-type bacteria in this low gastric pH mouse
model strongly correlated with their in vitro acid resistance profile
and that the arginine decarboxylase system provided approxi-
mately a 10-fold competitive advantage in the low pH gastric
environment for acid-sensitive strains of S. Typhi.
Materials and Methods
Animal use and ethics statement
This study was approved by the Arizona State University
Institutional Animal Care and Use Committee (IACUC). All
animals were housed in accordance with American Association for
Laboratory Animal Care (AALAC) standards, provided unlimited
access to food and water, and handled in accordance with the
Animal Welfare Act and Institutional Animal Care and Use
Committee (IACUC) regulations. Experiments involving animals
were conducted in a facility fully accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care
International (Unit #000765) and an assurance is on file with
the Office for Laboratory Animal Welfare (#A3217-01). Exper-
iments were planned and conducted utilizing the three R’s
(reduce, replace and refine) which included environmental
enrichment, veterinary oversight and the use of appropriate
analgesics and anesthesia when appropriate. For surgical proce-
dures, mice were anesthetized using pentobarbital. Euthanasia at
the completion of experiments was carried out by carbon dioxide
asphyxiation or cervical dislocation while under pentobarbital
anesthesia.
Bacterial strains, plasmids and culture conditions
The bacterial strains and plasmids used in this study are listed in
Table 1. For routine use, strains were propagated in LB medium
(supplemented with 0.1% glucose) with shaking at 200 rpm at
37uC [37]. For acid resistance and gastric transit assays, cells were
also grown in tryptic soy broth (TSB) (BD Biosciences, Franklin
Lakes, NJ, USA) with 0.4% glucose at 37uC under static anaerobic
conditions or in minimal EGA medium (E medium containing
0.4% glucose and 0.1% casamino acids [32]) with shaking at
200 rpm at 37uC. For S. Typhi strains containing the rhamnose-
dependent arginine decarboxylase system, 0.1% rhamnose was
supplied in the growth medium. S. Typhi EGA medium cultures
were supplemented with 20 mg/ml L-tryptophan, 22 mg/ml L-
cysteine, and 0.1% casamino acids. Media for the growth of DaroD
strains x11548 and x11568 were additionally supplied with 50 mg/
ml L-phenylalanine, 20 mg/ml L-tyrosine, 2 mg/ml r-aminoben-
zoic acid and 2.5 mg/ml 2, 3-dihydroxybenzoate. For antibiotic
selection, streptomycin and kanamycin were used at 30 mg/ml,
while ampicillin was used at 100 mg/ml. All chemicals were
purchased from Sigma-Aldrich (St. Louis, MO, USA) or Thermo
Fisher Scientific (Pittsburgh, PA, USA) unless otherwise indicated.
Histamine mouse model and measurement of murine
intragastric pH
Six week old, female BALB/c mice (Charles River Laboratories,
Wilmington, MA, USA) were fasted without food or water for 6 h
prior to the start of the experiment. Mice received the histamine
H1-receptor antagonist chlorpheniramine (0.3 mg/kg) subcutane-
ously to prevent allergy/anaphylaxis symptoms. Gastric acid
secretion was induced by subcutaneous injection of histamine
dihydrochloride (10 mg/kg) [33,34]. For intragastric pH mea-
surements, mice were anaesthetized with pentobarbital (50 mg/kg
intraperitoneally), stomachs were excised and the pH of the gastric
contents was immediately measured using an Orion 9863BN
Micro pH electrode (Thermo Fisher Scientific). Care was taken
during pH measurement to fully immerse the pH probe in the
gastric contents without contacting the stomach mucosa. Mice
were euthanized immediately after pH measurements were taken.
Visualization of S. Typhi in the gastrointestinal tract
As a means to visualize the location of the microbial inoculum
following oral immunization, the plasmid pGEN-luxCDABE was
introduced into S. Typhi Ty2. pGEN-luxCDABE encodes the Vibrio
luciferase genes and emits a strong photon signal (56105 CFU
emit a visible signal) [38]. This plasmid was stable for .25
generations in S. Typhi. Mice were treated to induce low gastric
pH as described above and were orally inoculated with
16109 CFU of S. Typhi Ty2(pGEN-luxCDABE) 50 min after
histamine injection. Bacterial cells were administered in 20 ml PBS
(pH 7.4) supplemented with 0.1% casamino acids. At 30, 60 and
90 min after inoculation, mice were euthanized via cervical
dislocation and the GI tract excised and perforated to increase
oxygen availability during the imaging process. Luminescent
bacteria were detected using the IVIS Lumina pre-clinical in vivo
A Murine Low Gastric pH Model
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imaging system (Xenogen, Alameda, CA, USA) using lumines-
cence settings with a 300 s exposure.
In vitro acid resistance assay
Acid resistance was determined essentially as described previ-
ously [39,40] with the following modifications. Wild-type strains
were propagated either under normal inoculation conditions
(grown to an optical density (OD600) of 0.9 in LB broth with 0.1%
glucose with aeration) or under acid resistance-inducing conditions
(in a static anaerobic TSB culture with 0.4% glucose for 17 h).
Cultures were normalized to the same OD600 value, then pelleted
and washed once in EG medium, pH 7.0 containing no growth
supplements [41]. Cells were pelleted a second time and
resuspended at a density of 16109 CFU/ml in EG medium at
pH 3.0 containing 0.1% casamino acids. Because the wild-type
strains use a variety of decarboxylase enzymes to resist low pH,
casamino acids were supplied in order to provide all strains with
the same combination of amino acids. Low pH challenge was
conducted at 37uC and samples were collected immediately after
resuspension (t = 0) and hourly for 4 h. Samples were serially
diluted and plated onto LB agar to assess viability during
challenge.
Gastric transit of wild-type enteric strains
Strains were grown under identical conditions as those used in
the acid resistance assay with two differences. First, strains used in
the gastric transit assays contained the low copy number plasmid
pWSK129 to allow for precise quantitation of strain numbers in
the non-sterile environment of the gastrointestinal tract. Second,
following the completion of growth, strains were pelleted and
resuspended in PBS [42] at a density of 561010 CFU/ml. Murine
gastric pH was lowered by histamine injection as described above
and groups of 5 mice were orally inoculated with 16109 CFU of
each strain 50 min after the administration of histamine. The
average gastric pH at the time of inoculation was 1.4660.25. Mice
were euthanized 1 h after inoculation and the entire small
intestine was removed, homogenized and serially diluted. Samples
were plated onto LB with kanamycin to determine the number of
viable bacteria present following low pH gastric transit.
Competition assay for acid-resistant and acid-sensitive S.
Typhi strains
The S. Typhi competition assay was performed the same as the
gastric transit assays with the following exceptions. First, compet-
itor strains contained one of two low copy number plasmids –
either pWSK129 or pGB2. No difference in gastric survival was
observed between strains containing these plasmids (data not
shown); however, to rule out any effect of antibiotic resistance on
gastric transit, each gastric passage experiment was repeated with
the plasmids switched. Second, following resuspension at
561010 CFU/ml, competitor strains were mixed to create an
inoculation material with equivalent numbers of each strain. The
cells of the inoculum were suspended in PBS containing 1 mM L-
arginine. After gastric transit, samples of homogenized intestinal
material were plated simultaneously onto LB agar with either
streptomycin or kanamycin to enumerate the number of each
strain present. Data are expressed as the competitive index for the
pair of strains. The number of acid-resistant microbes present was
divided by the number of acid-sensitive microbes and then
normalized by the initial inoculation ratio for each group.
Statistical analyses
Statistical calculations were performed using GraphPad Prism
version 6.00 for Windows (GraphPad Software, La Jolla, CA,
USA). Data are presented as the geometric mean 695%
confidence interval, with the exception of pH measurements
which are presented as the mean 6 SEM. 2-way ANOVA was
used to compare the performance of the fasted and histamine
mouse models over the entire strain set, and to compare the
difference between acid-adapted and unadapted cells. To deter-
Table 1. Bacterial strains and plasmids used in this study.
Strain Description/Genotypea Reference or Source
Escherichia coli O157:H7 278F2 Wild type [63]
Shigella flexneri 2457T Wild type [64]
Salmonella enterica serovar Typhimurium UK-1 Wild type [65]
Salmonella enterica serovar Typhimurium LT-2 Wild type, RpoS- [51,66]
Vibrio cholerae C6709 Wild type El Tor, Inaba [67]
Salmonella enterica serovar Typhi Ty2 Wild type, RpoS- [68,69]
x11548 S. Typhi Ty2 DaroD1299 [32]
x11568 S. Typhi Ty2 DaroD1299 DPadiA276::TT rhaSR PrhaBAD adiA D(PadiY-adiY-PadiC)-119 adiC [32]
x8444 S. Typhi Ty2 DphoPQ23 [32]
x11622 S. Typhi Ty2 DphoPQ23 DPadiA276::TT rhaSR PrhaBAD adiA D(PadiY-adiY-PadiC)-119 adiC [32]
x11118 S. Typhi Ty2 DPfur81::TT araC ParaBAD fur [32]
x11623 S. Typhi Ty2 DPfur81::TT araC ParaBAD fur DPadiA276::TT rhaSR PrhaBAD
adiA D(PadiY-adiY-PadiC)-119 adiC
[32]
Plasmid
pWSK129 pSC101 ori, KanR [70]
pGB2 pSC101 ori, Str/SpcR [71]
pGEN-luxCDABE p15A ori, AmpR, luxCDABE [38]
aIn genotype descriptions, the subscripted number refers to a composite deletion and insertion of the indicated gene. P, promoter; TT, T4 ip III transcription terminator;
ori, origin of replication; KanR, kanamycin resistance; Str/SpcR, streptomycin/spectinomycin resistance; AmpR, ampicillin resistance.
doi:10.1371/journal.pone.0087411.t001
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mine if the % survival of different strains in a particular model was
different, the non-parametric Kruskal-Wallis test was used. For the
correlation between survival in the mouse models and survival
during in vitro challenge, the log10 of the geometric mean number
of CFU that survived 1 h in vivo was plotted against the log10 of
the geometric mean number of CFU that survived 2 h at pH 3.0.
Linear regression analysis was used to calculate the best fit line and
r2 value. Competitive indices were analyzed by the Wilcoxon
signed rank test to determine whether the median value differed
significantly from 1.000.
Results
Optimization of the histamine mouse model for bacterial
gastric transit
Previous work with the histamine mouse model has shown that
maximal secretion of gastric acid occurs 45 min after the
administration of histamine [34]. However, this was reported as
the amount in mEq of HCl secreted from the mucosal surface and
not as the total gastric pH. To evaluate and validate the histamine
mouse model as a model for microbial gastric transit, it was
necessary to know the length of time required for the entire
contents of the stomach to acidify and the duration of the gastric
pH minimum so that an appropriate window for oral inoculation
could be selected. Thus, our first experiment monitored the gastric
pH for 4 h after induction of gastric acid secretion via histamine
injection (Figure 1). The mean initial gastric pH of mice that had
been fasting for 6 h at time 0 was 2.5460.31. The gastric pH
began to decrease 45 min after histamine injection (mean
pH=2.0160.19), but did not reach a minimum until 60 min
(mean pH=1.6160.03). The mean pH remained low at 90 min
(1.8460.08), but had returned to the initial value by 2 h
(2.7860.32). Based on these results, we chose to administer oral
inoculations to mice 50 min after the injection of histamine to
ensure that the incoming bacteria would enter a fully acidified
gastric compartment.
The other experimental parameter investigated was the length
of time needed for the orally administered bacteria to reach the
terminal ileum, which is the primary site of invasion for Salmonella.
In order to visually identify the location of the inoculated bacteria,
the pGEN-luxCDABE plasmid was introduced into S. Typhi Ty2.
Any site containing greater than 105 viable CFU will emit a visible
signal, so although the location of every microbe administered
could not be determined, the luciferase system encoded by the
plasmid was sufficient to detect the bolus of the inoculum. Within
30 min of oral inoculation, the majority of bacteria had already
transited the stomach and reached the upper portion of the small
intestine (Figure 2). By 60 min, the bacteria had reached the
terminal ileum, immediately prior to the cecum. After 90 min, the
bacteria had presumably entered the cecum, but were no longer
detectable, due either to their dilution into the cecal contents or a
lack of bioluminescence resulting from a prohibitively low oxygen
tension in the cecum. A faint visible signal was observed in the
stomachs of some mice. Plating indicated that although a small
portion of the inoculated microbes remained in the stomach
(approximately 5x103 CFU), the vast majority of bacteria exited to
the gastrointestinal tract (data not shown). Based on these results,
we selected 1 h after inoculation as the most opportune time to
recover the test bacteria from the gastrointestinal tract.
Enteric bacteria unprepared for low pH challenge survive
gastric passage in fasted but not histamine mice
If the histamine mouse model creates a low pH gastric barrier
similar to the one found in humans, then survival during transit
through the gastric compartment should correlate with the ability
of a microbe to resist low pH. In other words, the more acid-
resistant a particular pathogen is, the greater the number of
bacteria that survive low pH gastric transit. To test this, we
selected a panel of wild-type enteric bacteria with differing levels of
pH tolerance (Table 1). Escherichia coli O157:H7 and Shigella
flexneri were selected as highly acid-resistant strains. The E. coli
strain is capable of sustained survival at pH 2.0, while Shigella is
resistant to pH 2.5 [39,43,44]. Virulent Salmonella enterica serovar
Typhimurium strains such as UK-1 do not survive below pH 3.0
unless cultured under conditions that induce acid resistance
[43,45]. We also included S. Typhimurium LT-2, which has a
defect in the acid tolerance response and exhibits reduced survival
at pH 3.0 [27]. Acid-sensitive strains, Vibrio cholerae and Salmonella
enterica serovar Typhi, were also included. V. cholerae is highly
sensitive to low pH challenge [46]. While not as sensitive as V.
cholerae, S. Typhi strains generally have a much lower capacity to
resist low pH challenge than S. Typhimurium [15,47].
Cells were cultured under routine conditions in LB broth
(unprepared for low pH challenge), and their survival during in
vitro pH 3.0 challenge was compared to their survival during
gastric transit through fasted or histamine-treated mice (Figure 3).
During in vitro challenge, E. coli O157:H7 exhibited essentially no
decrease in viability over 4 h, while the viability of S. flexneri and
the S. Typhimurium strains declined gradually during the
experiment (Figure 3A). S. Typhi survived well for the first hour,
but a rapid loss in viability was observed after that. The acid-
sensitive V. cholerae strain exhibited the lowest level of survival.
These results are consistent with previously published studies
[15,27,39,43–46]. When the strains were passed through the
gastric compartments of fasted or histamine-treated mice, the
models produced significantly different results (p=0.0114)
(Figure 3B). In fasted mice, no differences in survival were
observed between strains (p=0.2757). In contrast, bacterial
survival during gastric transit in histamine-treated mice was
significantly different between strains (p,0.0001). The acid-
resistant S. flexneri strain had the highest rate of recovery
(1.3265.93%), followed by E. coli O157:H7
(2.3869.2461022%), while the acid-sensitive V. cholerae had the
Figure 1. Gastric pH following histamine injection. Following a 6
h fast, mice were injected at time 0 with 10 mg/kg histamine. The pH of
the gastric contents was monitored for 4 h post histamine injection.
Data shown are the mean and standard error of the mean of at least five
mice per time point.
doi:10.1371/journal.pone.0087411.g001
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lowest rate of recovery (1.67621.261025%). The acid-sensitive S.
Typhimurium LT-2 and S. Typhi strains also exhibited low rates
of recovery in the histamine mouse model (1.2762.2161023 and
1.8463.1961023, respectively). With the exception of S. flexneri,
the survival of each strain was significantly lower in the histamine
mouse than in the fasted mouse.
Induction of acid resistance increases survival of enteric
bacteria during gastric transit in histamine mice
If the differences in survival observed for different strains are
indeed due to differences in the ability of the strains to resist low
pH, then the induction of acid resistance prior to gastric transit
should increase the survival of previously acid-sensitive strains.
Thus, the experiment was repeated using cells that had been
cultured under anaerobic, low pH conditions to induce acid
tolerance and acid resistance (Figure 4). Under these conditions,
greater than 10% of the initial population of the E. coli, Shigella and
Salmonella strains were viable after 4 h of in vitro challenge
(Figure 4A). This was a significant increase over the survival of
unadapted cells (p=0.0011 for LT2, p,0.0001 for the other
strains). Although growth under acid resistance-inducing condi-
tions improved the ability of V. cholerae to survive at the later time
points of the challenge, the difference between acid-unadapted
and acid-adapted cells at pH 3.0 was not significant (p=0.2363).
When acid-adapted strains were administered to mice, survival
did not differ between the fasted and histamine-treated mouse
models (p=0.4648) (Figure 4B). This was a significant improve-
ment in survival during gastric transit over acid-unadapted cells
(p,0.0001). The greatest increases in survival in vivo were
observed with the E. coli O157:H7 strain, which increased from
2.3869.24x1022% to 27.3615.7% (p=0.0002) and the S. Typhi,
which increased from 1.8463.19x1023% to 1.2464.26%
(p=0.0002). Similar to the results observed during in vitro
challenge, acid adaptation of V. cholerae had no effect on in vivo
survival in histamine-treated mice (p=0.0626). To formally assess
the ability of the histamine mouse model to discriminate between
acid-sensitive and acid-resistant strains, we determined the
correlation between survival in vitro during pH 3.0 challenge
and survival in vivo (Figure 5). The histamine mouse model
demonstrated a clear correlation between acid resistance in vitro
and the ability to survive gastric transit through an acidified
compartment (r2 = 0.9399), indicating the power of this model to
distinguish between acid-sensitive and acid-resistant microbes
(Figure 5A). In contrast, the fasted mouse model showed only a
weak correlation between acid resistance and survival during in
vivo gastric transit (r2 = 0.4238) (Figure 5B).
A rhamnose-regulated arginine decarboxylase system
increases the survival of acid-sensitive S. Typhi strains
during gastric transit in histamine mice
We previously constructed a rhamnose-regulated arginine
decarboxylase system in S. Typhi, in which the adiA and adiC
genes are placed under the control of the rhamnose-dependent
promoter PrhaBAD [32]. Inclusion of rhamnose in the culture
medium results in expression of the arginine decarboxylase system,
significantly increasing survival during in vitro low pH challenge.
This system was introduced into three model S. Typhi vaccine
strains – DaroD1299 (x11548), DphoPQ (x8444) and DPfur81::TT
araC PBAD fur (x11118) (Table 1). The mutations in the phoPQ and
fur loci render their respective vaccine strains acid-sensitive, while
the mutation in aroD has no effect on acid sensitivity. Because the
histamine mouse model successfully discriminated between acid-
sensitive and acid-resistant bacteria, we used it to evaluate the
effectiveness of the rhamnose-regulated arginine decarboxylase
system in vivo. We found that the presence of our system provided
a competitive advantage during gastric transit (Figure 6). The
DaroD1299 vaccine strain benefitted the least from the acid
resistance system with only a 2.2-fold increase in the survival of
x11568 (AdiA+) over the original Daro parent strain (x11548). This
increase was not significant (p=0.2850). However, survival of the
acid-sensitive vaccine strains x8444 and x11118 (DphoPQ and
DPfur81::TT araC PBAD fur, respectively) was increased by the
presence of the rhamnose-inducible arginine decarboxylase system
in vivo. In the DPfur81::TT araC PBAD fur background, the presence
of arginine decarboxylase provided a 6.0-fold increase in survival
during gastric transit (p=0.0002). A greater degree of individual
Figure 2. Visualization of the bacterial inoculum in the gastrointestinal tract via light emission. Low gastric pH was induced in mice by
histamine injection prior to inoculation with 16109 CFU of S. Typhi Ty2(pGEN-luxCDABE). At 30, 60 and 90 min post-inoculation, the gastrointestinal
tract was removed and examined for the production of light by luciferase. A visible signal is equivalent to approximately 56105 CFU. Luminescence is
reported as the number of photons detected per s per square cm. Images shown are representative results from groups of seven mice.
doi:10.1371/journal.pone.0087411.g002
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variation was observed in the DphoPQ background, but the
inclusion of the regulated arginine decarboxylase system increased
survival 11.6-fold in vivo (p=0.0302).
Discussion
The fasted mouse model and the related bicarbonate-treated
fasted mouse model have been used extensively to evaluate the
immunogenicity of potential live attenuated S. Typhimurium
vaccine strains [1,48–50]. However, these models do not take into
account differences in the acid sensitivity of potential vaccine
strains. Although we observed a lower gastric pH in fasted mice
than previously reported (most likely due to differences in the
fasting conditions or length), acid-sensitive, acid-adapted and
naturally acid-resistant microbes all survived equally well during
their transit through the fasted gastric compartment. Although the
fasted mouse model is sufficient for the identification and initial
characterization of candidate RASVs, results obtained from this
model may be misleading because they do not take into account
the differences in murine and human gastric biology.
One of the goals of this study was to evaluate the ability of
histamine-treated mice to serve as a model system for assessing
gastric survival of microbes upon oral inoculation to humans. We
found the histamine mouse model to be a reliable means to induce
low gastric pH (approximately pH 1.5) for a considerable length of
time (45 min). Although the time that the orally administered
bacteria spend in the acidified gastric compartment is relatively
short (bacteria reach the jejunum within 30 min and are detected
in the terminal ileum approximately 1 h after inoculation), we
found that even this short exposure to low pH was sufficient to kill
Figure 3. Survival of strains cultured under non-acid resistance inducing conditions. Wild-type enteric strains were grown in LB medium
to late-log phase under aerobic conditions. (A) Cells were challenged in EG medium (pH 3.0) containing 0.1% casamino acids. Survival during EG
medium challenge was assayed hourly for 4 h by plating onto LB agar. Data shown are the mean and SEM of three independent experiments. (B)
Mice were either fasted for 6 h (fasted mouse model) or fasted and low gastric pH was induced by histamine injection (histamine mouse model) and
then inoculated with 109 CFU of each strain. Sixty min after inoculation, mice were euthanized and the entire small intestine removed and
homogenized. Strain survival was assayed by plating onto LB agar containing kanamycin. Data are expressed as the percent of initial inoculum
recovered (% survival). The geometric mean and 95% confidence interval of two independent experiments (8 mice total) is depicted.
doi:10.1371/journal.pone.0087411.g003
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a large number of the incoming microbes. Viability of the acid-
resistant E. coli O157:H7 and S. flexneri strains was reduced by 70–
90% during gastric transit, while the acid-sensitive V. cholerae strain
experienced a 100,000-fold decrease in viability.
The low pH gastric barrier created by the histamine mouse
model provides an in vivo system that accurately discriminates
between acid-sensitive and acid-resistant microbes. Survival
during gastric transit in this model directly correlated with the
ability of the test microbe to resist low pH. This holds even in the
case of the two S. Typhimurium strains tested, LT-2 and x3761
(Figure 3). This is of interest, since the two strains have a well-
characterized difference in acid resistance, due to their carriage of
different rpoS alleles [51]. Cells that were sensitive to acid or
unprepared for low pH challenge did not survive as well as cells
that had induced acid resistance systems prior to passage.
Although survival during gastric transit correlated well with the
acid resistance results obtained in vitro, the histamine mouse
model routinely returned lower rates of survival than the in vitro
assay. This could be due to the difference in pH between the in
vitro (3.0) and in vivo (1.5) challenges. However, it is also possible
that gastric transit poses additional challenges beyond low pH that
are not easily replicated in vitro. In vivo, ingested bacteria must
contend with a combination of organic and inorganic acids in the
stomach and upper intestinal tract [52] as well as the bile,
antimicrobial peptides and other intestinal defense mechanisms
[53–55]. Thus, when making predictions about the ability of a
given microbe to survive oral inoculation, it is important to
evaluate in vitro data cautiously, as a moderately acid-sensitive
strain in vitro may or may not efficiently transit the stomach in
vivo.
Figure 4. Survival of strains cultured under acid resistance-inducing conditions. Wild-type enteric strains were grown to stationary phase
in TSB medium containing 0.4% glucose under anaerobic conditions. (A) Cells were challenged in EG medium (pH 3.0) containing 0.1% casamino
acids. Survival was assayed hourly for 4 h by plating onto LB agar. Data shown are the mean and SEM of three independent experiments. (B) Mice
were either fasted for 6 h (fasted mouse model) or fasted and low gastric pH was induced by histamine injection (histamine mouse model) and then
inoculated with 109 CFU of each strain. Sixty min after inoculation, mice were euthanized and the entire small intestine removed and homogenized.
Strain survival was assayed by plating onto LB agar containing kanamycin. Data are expressed as the percent of initial inoculum recovered (%
survival). The geometric mean and 95% confidence interval of two independent experiments (8 mice total) is depicted.
doi:10.1371/journal.pone.0087411.g004
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Survival of acid-sensitive S. Typhi vaccines during gastric transit
was improved by the presence of a sugar-inducible acid resistance
system (rhamnose-regulated arginine decarboxylase). For both the
DphoPQ23 and DPfur81::TT araC ParaBAD fur strains, the inclusion of
this system greatly increased the number of viable bacteria that
reached their target tissue for invasion (the terminal ileum).
However, the inclusion of the arginine decarboxylase system did
not benefit the DaroD1299 mutant to the same degree as the acid-
sensitive strains. The reasons for this are not clear, since this strain
showed a dramatic increase in acid resistance during in vitro
challenge (10,000-fold greater viability after one hour) [32]. One
possibility is that growth in minimal medium prior to inoculation
may have rendered this nutritional mutant less fit for the challenge
of in vivo host interactions. Alternatively, the arginine decarbox-
ylase system may be able to compensate for defects in acid
tolerance or acid resistance but be unable to increase acid
resistance beyond the wild-type level. There is some evidence for
this, as the total number of CFU recovered for both the parent
DaroD1299 and acid-resistant DaroD1299 strains was higher than
the number recovered from the acid-resistant DphoPQ23 and
DPfur81::TT araC ParaBAD fur strains (data not shown).
In conclusion, the histamine mouse model is a method capable
of discriminating in vivo between acid-sensitive and acid-resistant
microbes. Survival during gastric transit in this model is directly
related to the ability of the ingested microbe to resist low pH - the
more acid-resistant a particular microbe is, the greater the number
of bacteria that survive gastric transit. This ability makes the
histamine mouse model an excellent choice to evaluate not just the
delivery of live recombinant attenuated S. Typhi vaccines, but any
beneficial orally administered microbe or gastric formulation
strategy. Many probiotic bacteria have low levels of acid tolerance
and require formulations that protect them from exposure to low
pH [56–59]. This model will allow those formulations to be tested
in vivo for efficacy. The histamine mouse model will also permit
researchers to explore the natural diversity of acid resistance or
sensitivity within a given species or between clinical isolates to
determine the effect of acid resistance on strain infectivity and
pathogenicity. Many pathogenic enterohemorrhagic E. coli strains
contain mutations in the rpoS and gadE genes (GadE is a regulator
of the glutamate decarboxylase system) and vary greatly in their
ability to resist low pH [8,60–62]. For microbes that exhibit acid
sensitivity, the inclusion of the rhamnose-regulated arginine
decarboxylase acid resistance system improves the ability of these
microbes to reach the intestinal tract. Future studies will focus on
determining whether this increase translates into a dose reduction
for the vaccine or improved vaccine efficacy.
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Figure 5. Correlation between in vitro and in vivo survival. The
log10 of the geometric mean number of CFU that survived in vitro
challenge at pH 3.0 for 2 h was plotted against the log10 of the
geometric mean number of CFU recovered from the intestinal tissue in
the (A) histamine mouse model or (B) fasted mouse model. Linear
regression was performed on each data set and the r2 value of the best-
fit line is depicted for each model.
doi:10.1371/journal.pone.0087411.g005
Figure 6. Effect of arginine decarboxylase on the gastric
survival of S. Typhi. Pairs of attenuated S. Typhi strains differing
only in their arginine decarboxylase locus were grown to stationary
phase in EGA medium under aerobic conditions. Cells were combined
in a 1:1 ratio in PBS containing 1 mM arginine. Low gastric pH was
induced by histamine injection in mice fasted for 6 h. Mice were
inoculated with 109 CFU of each strain. Sixty min after inoculation, mice
were euthanized and the entire small intestine removed and
homogenized. Strain survival was assayed by plating onto LB agar
containing kanamycin or streptomycin. Data shown are the competitive
index of the two strains in each mouse with the geometric mean of two
independent experiments (10 mice total) indicated as a solid line.
doi:10.1371/journal.pone.0087411.g006
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